Total Pageviews

After Crisis, Iceland Holds a Tight Grip on Its Banks

An angular glass building on the waterfront here used to be the headquarters of a banking giant with operations in Europe, North America and the Middle East.

Now, it houses a shadow of that behemoth â€" a small bank doing business only in Iceland and lacking both the trading culture and ambitions of its failed predecessor.

The metamorphosis is a result of one of the biggest bank crashes any country has ever had. The risk in Iceland’s financial system has dissipated, but the basic businesses of banking have shrunk as well. Lending to consumers and businesses has slowed to a fraction of what it was before the crisis.

“We moved from a situation where the one that took the biggest risk was the employee of the month, to a situation where the one that took the least risk became the employee of the month,” said Bjarni Benediktsson, the Icelandic finance minister. “I think we need to find a balance in between.”

Iceland is a living experiment in what can happen when a country forces its financial firms to go under, rather than bailing them out, as much of the rest of the world did during the global financial crisis.

In October 2008, all three of Iceland’s major banks collapsed. None failed more spectacularly than Kaupthing, the bank whose glass headquarters were on the waterfront. At one point, it had a balance sheet four times as large as the annual economic output of the entire country. Last month, four former Kaupthing executives were sentenced to multiple-year prison terms.

Emerging from the crisis are three new ventures, including Arion Bank, the successor to Kaupthing, that hold only the local assets of the old firms. They also have a different mind-set from the brash tenacity that prevails elsewhere in the financial industry.

“The mandate was to build a new bank on the foundations of the old collapsed bank,” said Hoskuldur Olafsson, the chief executive of Arion Bank, sitting in his sparsely decorated office overlooking the water. “It didn’t look good. It had no direction whatsoever. What we needed to do in the beginning was find some sort of a direction for where we would go with this bank.”

Iceland’s unusual path has been held up as a successful model of what can happen when a country opts to let its financial firms go under. The result in Iceland is that new banks are missing the big bonuses and risky trading desks that have fed populist anger elsewhere.

“We are a new bank with new business ethics and a new way of doing things,” said Steinthor Palsson, the chief executive who was brought on to run Landsbankinn, the largest of Iceland’s new banks. Revenue from trading operations at Landsbankinn is down to 10 percent of what it was in 2006.

But a transformation of the financial system can accomplish only such much in a country that faces such a long road to recovery.

Many companies and households in Iceland are still deeply indebted. Birgir Gudjonsson, a 37-year-old policeman in Reykjavik, said that the banks had been too interested in rebuilding their businesses and their balance sheets, and not helpful enough to homeowners like him who bought their first homes just before the crisis. Because many Icelandic loans are linked to inflation, Mr. Gudjonsson owes more than he initially borrowed.

“We’ve been hearing, almost weekly, ‘Oh look at this, everything is great,’ ” he said in the two-bedroom apartment where he lives with his wife and two daughters. “We just have to look in our wallet to see the reality.”

Companies and homeowners that want to borrow more are also having difficulty given the conservatism of the banks and a lack of access to foreign investors. In the first nine months of last year, for instance, Landsbankinn’s net new lending to corporations and individuals was 0.8 percent of what in was in all of 2006.

“There is no easy way out of a deep crisis,” said Mr. Benediktsson, the Icelandic finance minister, who recently came into office after an election that hinged on economic discontent.

Iceland’s leaders did not see bailouts as an alternative when they took control of the banks in October 2008. The three major banks were 10 times as large as the country’s gross domestic product, in contrast to the United States, where bank assets were about the same size as the annual G.D.P. Even if it wanted to, Iceland did not have the resources to save its banks.

Instead, the government took the banks and separated off all the loans and financial products that were outside Iceland â€" the majority of the assets â€" and stuffed them into a so-called bad bank with no government backing. The government also made it illegal to move money out of the country, halting a run on the local currency, the krona.

Even with these steps, the economy shrank 16 percent over the next year, and the unemployment rate rose to nearly 10 percent, from around 2 percent.

In Iceland, blame for the crisis fell almost entirely on the country’s financiers. While banks in other parts of the world were tangled up in bad bets on the American mortgage market, banks in Iceland had taken on mountains of debt to bet on speculative assets, and had spun a web of self-serving loans. Almost all the top executives were fired and many are now facing criminal prosecution.

Initially, the government was in charge of the banks, running them on an emergency basis. Soon, though, new companies were set up to oversee the mortgages and corporate loans in the country, with ownership split between the government and the creditors of the old banks.

To run the new companies, the government looked for people who were not tainted by involvement with the banks in the boom years. Mr. Palsson had been working outside Iceland, at a pharmaceutical company, when he was chosen to run Landsbankinn. Mr. Olafsson came to Arion Bank from the local subsidiary of Visa.

When these men arrived, they said, they faced entirely demoralized work forces, and a public that saw all bankers as villains. In a country where policemen do not carry guns, some bank executives were assigned guards to protect them at home.

“If the United States on the Richter scale was a three, Iceland was a nine,” said M.J. Bryant, a professor at the Ivey Business School in Canada who has written case studies on Iceland. “You have to place this all against the background of a complete betrayal of trust.”

After Mr. Palsson assumed the helm at Landsbankinn, he fired all eight executives directly beneath him and put advertisements for their jobs in a local newspaper. A new law required that his executive team be at least 40 percent women.

Mr. Palsson said he realized the first thing he had to do was improve the mood among the bank’s staff of 1,300 â€" down from 5,000 before the crash. He called all of the bank’s employees to Reykjavik’s main cinema, where he gave a pep talk with his new strategy.

He then moved to address the public’s anger, holding a series of public meetings around the country, where he sat on the stage with his other executives. Many of the meetings were filled with people berating Mr. Palsson’s team for the bank’s sins.

“Some people thought we were crazy doing this because people were very angry,” Mr. Palsson said. “But it was really a good therapy for many people who were angry.”

The banks’ first task was restructuring the loans of companies and households that could no longer pay them. The government passed a law mandating that loans had to be reduced to no more than 110 percent of the underlying property â€" helping homeowners who had ended up underwater, though it did not eliminate the inflation-linked loans that people like Mr. Gudjonsson have.

Landsbankinn went further and began a campaign to reduce the debt of any company or household that was unable to pay off its loans. This pressured the other banks to make similar efforts.

Another law made it illegal for banks to pay bonuses more than 25 percent of base salaries, and until recently none of the banks paid any bonuses at all.

But this has been one of the areas where the banks have realized the limits of reform. After some employees were poached by banks elsewhere in Scandinavia, where there were no bonus limits, Arion Bank and Islandsbank recently began offering bonuses for select executives.

The restructuring of the financial sector â€" and the government steps to protect the currency â€" have allowed unemployment to fall to 5.6 percent, and economic growth to begin.

Many economists, though, say that the banks are too focused on the past, and not doing enough to make new loans and build a business for the future. The banks have also been conservative about continuing to shrink their work force, which has left costs high.

“They are sort of in a standstill,” said Fridrik Mar Baldursson, a specialist in finance at Reykjavik University. “There is so much inertia in the system.”



How Banks Work, as Told by ABN Amro’s Chairman in Drag

In his former life as the finance minister for the Netherlands, Gerrit Zalm was known for his serious demeanor. But as chairman of ABN Amro, he has taken on a decidedly lighter tone on occasion.

To help explain the state-owned lender’s core values this month, Mr. Zalm dressed up as his “sister,” Priscilla, wearing a bright blue dress and a vivid red wig. Oh, and his fake sibling just happens to be a brothel owner.

You can watch the chairman’s performance, courtesy of a video that ABN Amro posted to its YouTube account on Tuesday. (We’re serious.) But in case your Dutch needs a little refreshing, here are a couple of choice quotes that we’ve translated â€" or at least ones that can run in a family publication:

  • “The bank can learn a lot from the best practices of my business.”
  • “Clients in my branch have a preference for younger relationship managers.”
  • [Referring to Mr. Zalm] “So he comes to me asking, ‘How did you do it?’ I reply: ‘You should start with core values. In my company, we have three: reliability, professionalism and ambition. We try to give the customer a warm welcome. We aim for long-term client relationships and we deliver what we’ve agreed upon. … We are experienced, well trained and can do it! We’re ambitious, and we always try to exceed the expectations of the customer.’ Well, he was very happy with that conversation.”

“Priscilla” described the advantages of her line of work, implying it took little effort to get a high return on equity and that running a brothel is almost like running a bank, but a tad better.

The character also said that like a bank, her business had “a good front office and an excellent back office.”

A spokesman for ABN Amro told Bloomberg News that Mr. Zalm delivered six performances as Priscilla for the bank’s employees, including four in Amsterdam. Referring to the ribald jokes, the spokesman added that the show “fits in with the Dutch sense of humor.”



Carlyle Said to Strike Deal for Johnson & Johnson Testing Division

The Carlyle Group has all but clinched a deal to buy Johnson & Johnson’s clinical testing arm for about $4.1 billion after several weeks of negotiations, a person briefed on the matter said on Wednesday.

A transaction could be announced as soon as Thursday, this person added. Any deal would involve nearly $1 billion in cash from the private equity firm’s latest leveraged buyout fund and about $3.3 billion in debt financing.

Carlyle emerged as the lead bidder late last month after an auction process that Johnson & Johnson has run for the division, which had drawn both private equity bidders and corporate suitors. Johnson & Johnson has been looking to sell slower-growing businesses as it focuses on higher-growth opportunities.

The business, known as Ortho Clinical Diagnostics, runs several medical tests, most prominently those for blood.

Carlyle has struck a number of health care deals in recent years, including a $3.9 billion takeover, with Hellman & Friedman, of the clinical drug testing company Pharmaceutical Product Development more than two years ago, and a $6.3 billion acquisition of the nursing home operator ManorCare in 2007.

News of the state of negotiations was reported earlier by The Wall Street Journal.



Lawmakers Press Fed to Limit Banks’ Involvement in Physical Commodities

WASHINGTON â€" Lawmakers on Wednesday pressed the Federal Reserve to act more forcefully, and quickly, to limit investment banks’ involvement in the physical commodities business, which has been blamed for inflating prices on everyday items like electricity and canned beverages.

For months, Congress has been evaluating complaints that the huge commodities holdings of investment banks like Goldman Sachs and Morgan Stanley pose a risk to the banking system. Businesses and consumer groups have also expressed concern that the banks’ financial heft gives them an unfair advantage over other competitors as well as the ability to manipulate prices for essentials like energy, cotton and food.

On Tuesday, the Fed said it was considering some new rules and issued a request for public comment. Even so, Senator Sherrod Brown, who chaired Wednesday’s hearing on the issue, said he was “incredulous” that the Fed had been examining the matter for six years and had yet to take action.

“The Fed’s proposal yesterday was a timid step,” said Senator Brown, a Democrat from Ohio. “It was too slow in coming, and there is still too much that we do not know about these activities and investments.”

Other members of the Senate subcommittee on financial institutions and consumer protection faulted the Fed for being overly focused on the internal workings of banks. In doing so, the lawmakers said the Fed overlooked the effect banks’ commodities activities may have ! on prices paid by the public.

When regulators evaluate a bank’s request to enter into a commodities-related business, they are supposed to weigh whether it will have a public benefit. But during questioning from Senator Jack Reed, an official from the Fed acknowledged that its evaluation process focused primarily on the bank.

“So the public interest test goes by the wayside,” said Senator Reed, a Democrat from Rhode Island.

“That’s the way it’s set up in the statute,” said the witness, Michael S. Gibson, the director of the Fed’s division of banking supervision and regulation.

The formal request released by the Fed on Tuesday seeks public input on 24 questions about how banks’ activities in the commodities business may benefit or harm consumers. In part, the request asked whether the commodities investments pose a significant risk to the banking system if banks incurred large losses in the volatile markets.

In the 19-page notice released Tuesday, the Fed referred to costly accidents in the commodities business in recent years, including the 2010 BP oil spill in the Gulf of Mexico, saying that a similar crisis at a bank-owned facility could endanger the financial system.

“The recent catastrophes accent that the costs of preventing accidents are high and the costs and liability related to physical commodity activities ca! n be diff! icult to limit and higher than expected,” the notice said.

Mr. Gibson testified that the Fed anticipated tighter regulation.

But it is unclear whether those regulations will prohibit or limit the banks commodities holdings or merely require higher capital reserves or more insurance.

The subcommittee held a similar hearing July, after an article in The New York Times reported that a chain of warehouses owned by Goldman Sachs had inflated the price of aluminum across the country. During that hearing, a witness from the brewing industry testified tha Goldman’s warehousing practices â€" which can create long delays for manufacturers, higher rent for the warehouse and an inflated storage premium â€" ultimately cost American consumers $3 billion per year.

While banks were for decades forbidden from owning or trading physical commodities, those regulations have been eased over the past 15 years. The Gramm Leach Bliley Act passed by Congress in 1999, which loosened restriction on the banking industry, contained a special grandfather clause that gave two banks â€" Goldman Sachs and Morgan Stanley â€" wider latitude to delve into commodities. In 2003, the Fed first permitted some commercial banks to handle physical commodities. After the financial crisis in 2008, the Fed also allowed some bank holding companies, including Goldman Sachs and Morgan Stanley, to retain their commodities units, as well as warehouses, ports, refineries and pipel! ines used! to store and ship them.

Banks, and many traders, say their commodities investments benefit consumers because the financial giants add liquidity to the market and help the warehousing and delivery systems to operate more efficiently.

But there have also been abuses. Last year, JPMorgan Chase and Deutsche Bank agreed to hefty settlements after investigations that they were rigging electricity prices. Norman C. Bay, head of enforcement for the Federal Energy Regulatory Commission, testified that his agency has collected more than $873 million in penalties since its regulatory powers were been broadened since the Enron electricity price-rigging scandal early last decade.

Mr. Ba said the agency plans to expand its monitoring of electricity markets in the coming months because it recently gained access to real-time data from the Commodity Futures Trading Commission that will help understand whether energy speculators are using futures swaps and other financial instruments as part of a strategy to manipulate prices.

The calls for tighter regulatory scrutiny over banks commodities investments during the past year have led some investment banks, including JPMorgan Chase, Goldman Sachs and Bank of America, to consider selling some or all of their commodities units. In his testimony, Mr. Gibson said the Fed had given JPMorgan a firm deadline to sell its commodities business, but he did not say when it is.



Skeptics Question Banks’ Bottom Lines

Some banks cheer an improvement to their bottom lines, but a debate is brewing over the calculations used to get there.

Bank of America and Wells Fargo reported profit rises in the fourth quarter, but some banking experts are concerned that Wall Street firms are quickly depleting a crucial type of rainy day fund.

As the economy has improved, banks have reduced how much money they set aside each quarter to build up the financial cushions that they must maintain to absorb potential losses from bad loans. Adding to the buffer, known as the loan loss reserve, is an expense that comes out of profits. Cutting back on this expense has been a huge lift to big banks’ bottom lines for many months. But the practice is also becoming a concern to regulators. The Office of the Comptroller of the Currency, for instance, warned the industry last year that bank earnings should not become dependent on the help they get from adding less to their reserves.

“You almost kind of have a tug of war going on,” said Jason Goldberg, an analyst with Barclays.

On Tuesday, Wells Fargo reported profit of $22 billion in 2013 and disclosed it had set aside nearly $5 billion less in loan loss reserves last year than it did in 2012. On Wednesday, Bank of America reported profit of $11 billion last year, and said it had set aside about $4.6 billion less in 2013 than it had in 2012.

The banks contend that the drop in bad loan expense is justified because their losses from bad loans, called charge-offs, are declining. “We have seen a dramatic reduction in charge-offs over the past couple of years as credit quality has improved across all of our portfolios, and we are adjusting our reserves accordingly,” a Bank of America spokesman said.

The comptroller commented on the lower bad loan expenses in a report last year. It noted that the largest banks had reduced the amounts they added to their reserves by 29 percent in the 12 months through June 2013.

Regulators keep a close eye on reserves because they want them to be big enough to absorb losses. Right now, with the economy picking up, and banks making fewer risky loans than before the financial crisis, banking analysts do not expect banks to become overwhelmed with bad loans. Still, like all rainy day funds, they have to be sufficient to cover even unexpected and potentially severe losses.

Analysts have different ways of assessing the strength of a bank’s loan loss reserve. For instance, they compare the reserve with a bank’s nonperforming loans, which are loans that show signs that they may not be repaid in full. Bank of America’s reserve, for example, exceeded its nonperforming loans by a small margin at the end of 2013. That margin was only slightly smaller than it was at the end of 2012.

Having to contribute less to those reserves is one of the reasons that Wall Street stocks have been on fire in 2013. “Maybe some banks are already getting that artificial boost,” said Gerard Cassidy, an analyst with RBC Capital Markets. “The market doesn’t discriminate as much as people would think.”

Still, the comptroller is worried that banks may not be fully recognizing problems brewing in their loan portfolio as they add less to their reserves. “The pace and magnitude of releases from allowance for loan and lease losses compared with underlying credit trends reveal a growing disconnect,” the regulators said in the report.

Peter Eavis contributed reporting.



At JPMorgan’s Health Care Conference, Deal Talk Abounds

Few events are bigger in the world of corporate health care than JPMorgan Chase’s annual conference in San Francisco. And this year, much of the buzz seems to surround the prospect of more deals.

More than a few major drug makers have mentioned a desire to pursue takeovers this year to help add new products, according to news reports.

Such attitudes have been prevalent in the health care industry for some time. The sector has been one of the busier areas of focus for deal makers, as drug makers look to refill their product pipelines, and service providers look to gain scale and move into complementary businesses.

Health care transactions comprised about 8.5 percent of deals announced globally last year, according to Thomson Reuters.

Among the potential buyers is Bristol-Myers Squibb, whose chief financial officer told Bloomberg News that the company remains interested in buying new drugs, despite disappointing returns on the nearly $8 billion it’s spent on deals over the past three years. This time, it will look more to drugs in the earlier stages of testing.

Here’s what Charles Bancroft, Bristol-Myers’ chief financial officer, told the news service:

“We have to take bets sometimes,” Bancroft said. “A really good company shows they can be adaptable and flexible to the environment they find themselves in at any given time.”

Teva Pharmaceuticals also spoke of looking to deals as a growth strategy once more, after taking a sabbatical from being one of the most merger-focused pharmaceutical companies.

From Bloomberg’s account of comments by Eyal Desheh, Teva’s chief financial officer:

“We have to do the clever deals that Teva was so good at doing in the past,” Chief Financial Officer Eyal Desheh said yesterday at a JPMorgan Chase & Co. health-care conference in San Francisco. “The ones that you can buy one and one and get to two, I know it’s a cliché. But we’re very good at doing that. And I think that these are the kind of deals that we’ll be looking at in the future.”

And Covidien, the medical device maker that was spun off from Tyco, said that it plans to use its free cash flow for strategic acquisitions, according to a transcription of comments by Joe Almeida, the company’s chairman and chief executive.

More from Mr. Almeida’s presentation:

Covidien has the preference of spending money and acquisitions that will deliver strategically and financially to our shareholders. And it is important to understand that the acquisition world is very opportunistic and any time the Covidien has cash sitting in its balance sheet will not sit there for long.



A Case of Mistaken Identity Sends a Worthless Stock Soaring

Nestor Inc. is a defunct shell of a company that once sold automated traffic enforcement equipment to state and local governments. Based in Providence, R.I., the company went into receivership in 2009, and all of its assets have been sold.

Its shares, which are not listed on any exchange, have been dormant for years, worth less than a penny each.

But on Tuesday, the stock woke suddenly from its long slumber to begin trading at one penny, jumping to a high of 10 cents a share. After a volatile day of trading, it closed at 4 cents.

So, what happened? The price movement may be a case of mistaken identity stemming from an acquisition announced this week.

Google said on Monday it had agreed to buy Nest Labs, which makes Internet-connected devices like thermostats and smoke alarms, for $3.2 billion in cash. Nest Labs is a private company based in Palo Alto, Calif.

After the deal was announced, investors rushed to buy shares of Nestor, apparently confused by the company’s ticker symbol, NEST. The stock continued trading on Wednesday, settling at about 4 cents a share by midday.

This isn’t the first time that a big deal on Wall Street has reverberated in the shadowy world of penny stocks. In October, after Twitter filed to go public, shares of Tweeter Home Entertainment â€" a defunct home entertainment retailer whose stock had barely traded â€" surged as much as 685 percent before trading was halted.

At this point, Nestor Inc. is not much more than a hollowed-out carcass. After the company folded in 2009, lawyers oversaw the sale of its assets to American Traffic Solutions, a company in Arizona. But while the assets were sold, the entity itself was not â€" leaving behind an essentially worthless stock.

“I have gotten calls from shareholders periodically asking me: What are my shares worth?” said Stephen F. DelSesto, a lawyer at Shechtman Halperin Savage who managed Nestor’s business while it was in receivership. “I’ve told them, ‘They’re probably not worth the paper that they’re printed on.’”

The trading activity in Nestor set off a round of chatter online on Wednesday, after the pseudonymous blogger Kid Dynamite posted a stock chart. Matt Levine, a writer for Bloomberg View, pondered a hypothetical legal question.



A Case of Mistaken Identity Sends a Worthless Stock Soaring

Nestor Inc. is a defunct shell of a company that once sold automated traffic enforcement equipment to state and local governments. Based in Providence, R.I., the company went into receivership in 2009, and all of its assets have been sold.

Its shares, which are not listed on any exchange, have been dormant for years, worth less than a penny each.

But on Tuesday, the stock woke suddenly from its long slumber to begin trading at one penny, jumping to a high of 10 cents a share. After a volatile day of trading, it closed at 4 cents.

So, what happened? The price movement may be a case of mistaken identity stemming from an acquisition announced this week.

Google said on Monday it had agreed to buy Nest Labs, which makes Internet-connected devices like thermostats and smoke alarms, for $3.2 billion in cash. Nest Labs is a private company based in Palo Alto, Calif.

After the deal was announced, investors rushed to buy shares of Nestor, apparently confused by the company’s ticker symbol, NEST. The stock continued trading on Wednesday, settling at about 4 cents a share by midday.

This isn’t the first time that a big deal on Wall Street has reverberated in the shadowy world of penny stocks. In October, after Twitter filed to go public, shares of Tweeter Home Entertainment â€" a defunct home entertainment retailer whose stock had barely traded â€" surged as much as 685 percent before trading was halted.

At this point, Nestor Inc. is not much more than a hollowed-out carcass. After the company folded in 2009, lawyers oversaw the sale of its assets to American Traffic Solutions, a company in Arizona. But while the assets were sold, the entity itself was not â€" leaving behind an essentially worthless stock.

“I have gotten calls from shareholders periodically asking me: What are my shares worth?” said Stephen F. DelSesto, a lawyer at Shechtman Halperin Savage who managed Nestor’s business while it was in receivership. “I’ve told them, ‘They’re probably not worth the paper that they’re printed on.’”

The trading activity in Nestor set off a round of chatter online on Wednesday, after the pseudonymous blogger Kid Dynamite posted a stock chart. Matt Levine, a writer for Bloomberg View, pondered a hypothetical legal question.



Skeptics Question Banks’ Bottom Lines

Some banks cheer an improvement to their bottom lines, but a debate is brewing over the calculations used to get there.

Bank of America and Wells Fargo reported profit rises in the fourth quarter, but some banking experts are concerned that Wall Street firms are quickly depleting a crucial type of rainy day fund.

As the economy has improved, banks have reduced how much money they set aside each quarter to build up the financial cushions that they must maintain to absorb potential losses from bad loans. Adding to the buffer, known as the loan loss reserve, is an expense that comes out of profits. Cutting back on this expense has been a huge lift to big banks’ bottom lines for many months. But the practice is also becoming a concern to regulators. The Office of the Comptroller of the Currency, for instance, warned the industry last year that bank earnings should not become dependent on the help they get from adding less to their reserves.

“You almost kind of have a tug of war going on,” said Jason Goldberg, an analyst with Barclays.

On Tuesday, Wells Fargo reported profit of $22 billion in 2013 and disclosed it had set aside nearly $5 billion less in loan loss reserves last year than it did in 2012. On Wednesday, Bank of America reported profit of $11 billion last year, and said it had set aside about $4.6 billion less in 2013 than it had in 2012.

The banks contend that the drop in bad loan expense is justified because their losses from bad loans, called charge-offs, are declining. “We have seen a dramatic reduction in charge-offs over the past couple of years as credit quality has improved across all of our portfolios, and we are adjusting our reserves accordingly,” a Bank of America spokesman said.

The comptroller commented on the lower bad loan expenses in a report last year. It noted that the largest banks had reduced the amounts they added to their reserves by 29 percent in the 12 months through June 2013.

Regulators keep a close eye on reserves because they want them to be big enough to absorb losses. Right now, with the economy picking up, and banks making fewer risky loans than before the financial crisis, banking analysts do not expect banks to become overwhelmed with bad loans. Still, like all rainy day funds, they have to be sufficient to cover even unexpected and potentially severe losses.

Analysts have different ways of assessing the strength of a bank’s loan loss reserve. For instance, they compare the reserve with a bank’s nonperforming loans, which are loans that show signs that they may not be repaid in full. Bank of America’s reserve, for example, exceeded its nonperforming loans by a small margin at the end of 2013. That margin was only slightly smaller than it was at the end of 2012.

Having to contribute less to those reserves is one of the reasons that Wall Street stocks have been on fire in 2013. “Maybe some banks are already getting that artificial boost,” said Gerard Cassidy, an analyst with RBC Capital Markets. “The market doesn’t discriminate as much as people would think.”

Still, the comptroller is worried that banks may not be fully recognizing problems brewing in their loan portfolio as they add less to their reserves. “The pace and magnitude of releases from allowance for loan and lease losses compared with underlying credit trends reveal a growing disconnect,” the regulators said in the report.

Peter Eavis contributed reporting.



At JPMorgan’s Health Care Conference, Deal Talk Abounds

Few events are bigger in the world of corporate health care than JPMorgan Chase’s annual conference in San Francisco. And this year, much of the buzz seems to surround the prospect of more deals.

More than a few major drug makers have mentioned a desire to pursue takeovers this year to help add new products, according to news reports.

Such attitudes have been prevalent in the health care industry for some time. The sector has been one of the busier areas of focus for deal makers, as drug makers look to refill their product pipelines, and service providers look to gain scale and move into complementary businesses.

Health care transactions comprised about 8.5 percent of deals announced globally last year, according to Thomson Reuters.

Among the potential buyers is Bristol-Myers Squibb, whose chief financial officer told Bloomberg News that the company remains interested in buying new drugs, despite disappointing returns on the nearly $8 billion it’s spent on deals over the past three years. This time, it will look more to drugs in the earlier stages of testing.

Here’s what Charles Bancroft, Bristol-Myers’ chief financial officer, told the news service:

“We have to take bets sometimes,” Bancroft said. “A really good company shows they can be adaptable and flexible to the environment they find themselves in at any given time.”

Teva Pharmaceuticals also spoke of looking to deals as a growth strategy once more, after taking a sabbatical from being one of the most merger-focused pharmaceutical companies.

From Bloomberg’s account of comments by Eyal Desheh, Teva’s chief financial officer:

“We have to do the clever deals that Teva was so good at doing in the past,” Chief Financial Officer Eyal Desheh said yesterday at a JPMorgan Chase & Co. health-care conference in San Francisco. “The ones that you can buy one and one and get to two, I know it’s a cliché. But we’re very good at doing that. And I think that these are the kind of deals that we’ll be looking at in the future.”

And Covidien, the medical device maker that was spun off from Tyco, said that it plans to use its free cash flow for strategic acquisitions, according to a transcription of comments by Joe Almeida, the company’s chairman and chief executive.

More from Mr. Almeida’s presentation:

Covidien has the preference of spending money and acquisitions that will deliver strategically and financially to our shareholders. And it is important to understand that the acquisition world is very opportunistic and any time the Covidien has cash sitting in its balance sheet will not sit there for long.



Doctor at Insider Trading Trial Testifies, ‘It Was Like He Was in the Room’

Prosecutors may not have any taped conversations showing how a former SAC Capital Advisors hedge fund manager, Mathew Martoma, engineered what they have called the biggest insider trading scheme in history. But testimony from one doctor indicates that Mr. Martoma knew the specific results of a clinical drug trial before they were publicly known.

On the witness stand for a second day on Wednesday, Dr. Joel S. Ross told the jury how Mr. Martoma knew so much detail about a confidential presentation that Dr. Ross and other medical experts had just listened to, “It was like he was in the room with me and the slides I had just seen.”

The presentation was given by Dr. Michael Grundman, vice president of clinical development at Elan, on July 28, 2008. It was the first time that investigators in a clinical trial for an Alzheimer’s drug being developed by Elan and Wyeth were made privy to the results of the trial. The results, which were negative, would not be publicly announced until the following day, sending the share prices of Elan and Wyeth down sharply.

Knowing the results ahead of the public announcement gave Mr. Martoma an “illegal edge” that helped SAC avoid losses and make gains of $276 million, the government contends. Mr. Martoma’s case, which includes two counts of securities fraud and one count of conspiracy, turns on testimony from Dr. Ross and a second doctor who participated in the drug trial.

Dr. Sidney Gilman, the second doctor and the government’s star witness, is an 81-year-old retired University of Michigan professor. He has not yet testified, but Mr. Martoma’s lawyers have already sought to discredit him, raising questions about his memory. Dr. Gilman was undergoing cancer treatment in the years that Mr. Martoma cultivated a relationship with him, and one of the drugs he was taking at the time is known to cause “confusion,” Richard Strassberg, one of Mr. Martoma’s lawyers, said in his opening statement.

Dr. Ross testified on Tuesday that he was introduced to Mr. Martoma through HCRC, a firm that arranged for paid consultations between investors and experts in specific fields. While Mr. Martoma paid for many meetings with Dr. Ross (at the rate of $1,500 an hour), the two met on several occasions outside of those meetings, the jury was told.

At one point, Dr. Ross said he asked Mr. Martoma to help introduce him to biotechnology companies that might be interested in using his newly opened research center to conduct their clinical trials. Mr. Martoma promised to help, Dr. Ross testified.

On Tuesday, jurors were shown emails between the two arranging to meet the night before Elan would publicly announce the results of the second phase of its clinical trial to test the Alzheimer’s drug called bapineuzumab. Dr. Ross testified that he left the meeting about the final trial results early to meet with Mr. Martoma.

On Wednesday, Dr. Ross elaborated on his meeting with Mr. Martoma, which took place in the lobby of the Hyatt McCormick in Chicago, and described his surprise at hearing Mr. Martoma discuss details about the trial results that Dr. Ross had not yet given him.

Dr. Ross said he told Mr. Martoma that he was still optimistic despite negative results. But, Dr. Ross recalled, “He said, ‘I don’t understand how you can say that with the statistical evidence showing otherwise.’”

Asked when was the last time he saw Mr. Martoma, Dr. Ross replied that it was nearly six years ago in that Hyatt McCormick lobby. He told the jury that Mr. Martoma never referred him to any biotechnology companies.

The defense began to cross-examine Dr. Ross just before the jury took a break for lunch and will continue on Wednesday afternoon.



Doctor at Insider Trading Trial Testifies, ‘It Was Like He Was in the Room’

Prosecutors may not have any taped conversations showing how a former SAC Capital Advisors hedge fund manager, Mathew Martoma, engineered what they have called the biggest insider trading scheme in history. But testimony from one doctor indicates that Mr. Martoma knew the specific results of a clinical drug trial before they were publicly known.

On the witness stand for a second day on Wednesday, Dr. Joel S. Ross told the jury how Mr. Martoma knew so much detail about a confidential presentation that Dr. Ross and other medical experts had just listened to, “It was like he was in the room with me and the slides I had just seen.”

The presentation was given by Dr. Michael Grundman, vice president of clinical development at Elan, on July 28, 2008. It was the first time that investigators in a clinical trial for an Alzheimer’s drug being developed by Elan and Wyeth were made privy to the results of the trial. The results, which were negative, would not be publicly announced until the following day, sending the share prices of Elan and Wyeth down sharply.

Knowing the results ahead of the public announcement gave Mr. Martoma an “illegal edge” that helped SAC avoid losses and make gains of $276 million, the government contends. Mr. Martoma’s case, which includes two counts of securities fraud and one count of conspiracy, turns on testimony from Dr. Ross and a second doctor who participated in the drug trial.

Dr. Sidney Gilman, the second doctor and the government’s star witness, is an 81-year-old retired University of Michigan professor. He has not yet testified, but Mr. Martoma’s lawyers have already sought to discredit him, raising questions about his memory. Dr. Gilman was undergoing cancer treatment in the years that Mr. Martoma cultivated a relationship with him, and one of the drugs he was taking at the time is known to cause “confusion,” Richard Strassberg, one of Mr. Martoma’s lawyers, said in his opening statement.

Dr. Ross testified on Tuesday that he was introduced to Mr. Martoma through HCRC, a firm that arranged for paid consultations between investors and experts in specific fields. While Mr. Martoma paid for many meetings with Dr. Ross (at the rate of $1,500 an hour), the two met on several occasions outside of those meetings, the jury was told.

At one point, Dr. Ross said he asked Mr. Martoma to help introduce him to biotechnology companies that might be interested in using his newly opened research center to conduct their clinical trials. Mr. Martoma promised to help, Dr. Ross testified.

On Tuesday, jurors were shown emails between the two arranging to meet the night before Elan would publicly announce the results of the second phase of its clinical trial to test the Alzheimer’s drug called bapineuzumab. Dr. Ross testified that he left the meeting about the final trial results early to meet with Mr. Martoma.

On Wednesday, Dr. Ross elaborated on his meeting with Mr. Martoma, which took place in the lobby of the Hyatt McCormick in Chicago, and described his surprise at hearing Mr. Martoma discuss details about the trial results that Dr. Ross had not yet given him.

Dr. Ross said he told Mr. Martoma that he was still optimistic despite negative results. But, Dr. Ross recalled, “He said, ‘I don’t understand how you can say that with the statistical evidence showing otherwise.’”

Asked when was the last time he saw Mr. Martoma, Dr. Ross replied that it was nearly six years ago in that Hyatt McCormick lobby. He told the jury that Mr. Martoma never referred him to any biotechnology companies.

The defense began to cross-examine Dr. Ross just before the jury took a break for lunch and will continue on Wednesday afternoon.



G.M.’s Dividend Hits the Right Spot

General Motors is hitting the right spot on several levels with its return to paying a common stock dividend.

The $1.7 billion annual payout looks punchy at some 30 percent of what analysts reckon the company’s net income will be for 2013. Ford Motor, after all, restarted its shareholder payouts at a more cautious 10 percent of profit just over two years ago and only last week took it up to around a third. But GM looks positioned to handle it.

The company’s bottom line, for example, may jump by more than a third this year to $7.8 billion, according to consensus estimates compiled by Thomson Reuters. The dividend would then equate to only just over 20 percent of earnings.

On top of that, G.M. is generating around $1.5 billion of free cash flow a quarter and it had nearly $29 billion of cash and marketable securities at the end of the third quarter of 2013. That’s far more than enough to cover the dividend and any unexpected calls on its resources.

There could be several of those. The company’s European operation is not expected to return to profitability for a year or two. Strong competition in the U.S. small and mid-sized car market has raised fears of a price war - and, as the new leaders in that segment, GM and Ford would be the targets rather than the instigators they were before the financial crisis.

Moreover, G.M. may decide to splash out in an attempt to bolster its overall share of its home market from the 17.9 percent where it has been stuck for the past couple of years. A domestic fight has the potential to dent net income for a number of players, should it happen. Detroit’s largest manufacturer, though, should be able to manage it.

It’s notable that G.M. board is reinstating the company’s dividend before sorting out new pay levels for its top executives. These have been restricted since the company took $50 billion of bailout money from the U.S. government in 2009. The last of that was repaid in December - with taxpayers taking a $10 billion hit - so directors can bump up compensation soon to more typical private-sector levels. Restoring investor payouts first implies the company is putting shareholders ahead of employees, which rarely seemed the case before the bailout.

G.M. still has work to do. But Mary Barra, who takes over as chief executive on Wednesday, looks set for a good first day on the job.

Antony Currie is an associate editor at Reuters Breakingviews. For more independent commentary and analysis, visit breakingviews.com.



Want Better Hedge Fund Returns? Try One Led by a Woman

In the world of hedge funds, a relative few have a woman at the helm. And yet, these funds may be the standouts from the bunch, a new report argues.

In the years since the financial crisis, hedge funds managed by women performed better than a broader index that reflects the performance of the industry, according to a report released on Wednesday by the professional services firm Rothstein Kass. The report seeks to show that this “alpha” - superior returns, in Wall Street speak - is no mere fluke.

“There is meaningful alpha to be gained from investing in women-owned and -managed funds,” Meredith Jones, a director at Rothstein Kass who wrote the report, said in an interview. “There appear to be both behavioral and biological factors that impact women’s ability to manage money and make them consistent.”

From the beginning of 2007 through June 2013 - a period that includes the dark days of the crisis - a Rothstein Kass index of women-run hedge funds returned 6 percent, the report says. By comparison, the HFRX Global Hedge Fund Index, released by Hedge Fund Research, fell 1.1 percent during that time, according to the report.

Last year through November, the index of women-run funds had a 9.8 percent return, compared with a 6.13 percent rise in the broader index, the research showed. (Still, both indexes fell short of the Standard & Poor’s 500-stock index, which rose about 27 percent during that time.)

The report, titled “Women in Alternative Investments: A Marathon, Not a Sprint,” used a group of 82 hedge funds managed or owned by women. Last year, the firm said that female hedge fund managers produced a return of 8.95 percent through the third quarter of 2012, compared with a 2.69 percent net return for the broader index.

While highlighting the accomplishments of women in hedge funds, private equity and venture capital, this year’s report also draws attention to persistent gender disparities on Wall Street.

The research, based on a survey in September and October of 440 senior women in the alternative investments business, suggests that the vast majority of the top jobs are held by men. Of the women surveyed, only 15.5 percent said their firm was owned or managed by a woman. Among hedge funds in particular, 21.4 percent were owned or managed by women.

About 42 percent of the respondents said that their firm had no general partners who were women. And nearly 40 percent of the firms included in the survey had no women on their investment committees.

In that context, hedge funds run by women remain something of a niche. Some institutional investors, like public pension funds, have a specific mandate to invest a portion of their money in funds run by women or minorities.

Though these mandates can be motivated by political factors, Rothstein Kass is seeking to show that investing with women managers can be a wise choice for purely financial reasons. A handful of studies have suggested that women traders behave differently than their male counterparts, acting less impulsively.

John Coates, a former trader who is now a research fellow in neuroscience at the University of Cambridge, argued in a 2012 book, “The Hour Between Dog and Wolf,” that testosterone contributed to market swings. Hiring more women on trading floors, he wrote, might have a stabilizing effect.

But these ideas are far from mainstream, and the industry has been slow to change. A fourth of investors surveyed by Rothstein Kass said they expected their allocations to women-run funds to increase “somewhat” in 2014, while 2 percent expected to allocate “significantly” more money.

Though the study expected more women to start their own funds in the coming years, the scarcity of such funds is itself an obstacle, a “chicken or the egg” problem, said Kelly Easterling, an audit principal at Rothstein Kass who contributed to the report.

“Without a large supply of funds, it’s difficult to achieve appropriate portfolio diversification or, for that matter, put enough money to work to move the performance dial,” she said in a statement quoted in the report. “On the other hand, until there is more money flowing to women-owned and -managed funds, it’s unlikely that there will be a stampede of new fund launches.”



Richard Parsons’s New Restaurant Receives Accolades

Richard D. Parsons has held many titles during his career: media conglomerate chief, chairman of Citigroup, wearer of leather jackets.

Now he can add “co-owner of a critically praised restaurant” to his résumé.

The New York Times on Wednesday gave high marks to the Cecil, a restaurant that counts Mr. Parsons and Alexander Smalls, a former opera singer, as owners. The two men are already partners in Minton’s Playhouse, a revival of the legendary Harlem jazz bar that is nearby.

The Times’s Ligaya Mishan gave high marks to the Cecil’s “Afro/Asian/American” cuisine, as prepared under the guidance of the chef Joseph Johnson. More from the review:

Some dishes verge on monumental, like gumbo with a pleasingly sour undertow of dried shrimp and feijoada, a Brazilian black-bean stew stuffed with a whole merguez lamb sausage and crowned with a slab of oxtail whose daunting layer of fat arrives already melting.

But many of the pleasures here are subtle. For wild bass, Mr. Johnson draws on a jerk recipe from his great-aunt in Barbados, balancing the heat with soy, orange and lime zest so the dish soothes rather than inflames. Wok-fried lo mein noodles, accompanying a hearty duck leg, are tinged with a delicate Indian-style cashew broth.



Riverbed Rejects Elliott’s $3.2 Billion Takeover Bid

Riverbed Technology announced on Wednesday that it had rejected a $3.2 billion takeover bid by the hedge fund Elliott Management and announced preliminary results for its fourth quarter that were better than expected.

In a statement, the company described Elliott’s offer of $19 a share as inadequate. The networking equipment maker didn’t say whether it would take the activist hedge fund up on its other demand: setting up a process to sell itself. But it didn’t close the door on such a move, either.

“While the board will carefully review any credible offer made to acquire the company, any such offer must deliver value to our shareholders in excess of what we believe will be created as we execute on our growth plans and capitalize on the significant investments we have already made in that regard,” Jerry M. Kennelly, Riverbed’s chairman and chief executive, said in a statement.

While Elliott has made a takeover offer for Riverbed, the hedge fund is clearly trying to flush out other bidders for the company, which makes services to speed up network performance. The activist investor believes that an array of private equity firms and strategic rivals would express interest in buying the company.

For now, however, Riverbed appears to have bought itself some time with an early look at its fourth-quarter performance. It expects to report pro forma revenue of $284 million to $285 million, up from its previous guidance of $270 million to $276 million. And pro forma profit should come in at 30 cents to 31 cents per diluted share, well above its previous forecasts of 26 cents to 27 cents.

Shares in the company were up 1.8 percent in premarket trading on Wednesday, at $19.79.

Elliott will likely be happy with the better-than-expected results. But in a letter sent to the company’s board on Tuesday, the hedge fund warned that a sale would likely generate more value for shareholders than a standalone self-help plan, and supplied a number of quotes in support of beginning an auction process.

Elliott specifically outlined two paths that Riverbed could take: begin talking to prospective buyers, or reject any notion of entertaining a takeover bid. The latter, the activist investor argued, “deprives shareholders of the opportunity to explore a certain and substantial premium in favor of sight-unseen assurances from Riverbed that it has a plan that will lead to a better outcome.”

The letter was sent ahead of a company board meeting held on Tuesday, in the hopes of keeping pressure on directors to consider forming a sales process.

A spokesman for Elliott did not have immediate comment.

Riverbed is being advised by Goldman Sachs and the law firm Wilson Sonsini Goodrich & Rosati.



Good News for Bank of America

Bank of America posted fourth-quarter results on Wednesday that exceeded Wall Street expectations, driven by decreasing expenses in its mortgage business. Earnings rose to $3.4 billion, or 29 cents a share, from $732 million, or 3 cents a share, in the period a year earlier, Michael Corkery reports in DealBook. Earnings exceeded the 26 cents a share that analysts had expected. Net revenue rose 15 percent, to $21.7 billion.

“Capital and liquidity are at record levels, credit losses are at historic lows, our cost savings initiatives are on track and yielding significant savings, and our businesses are seeing good momentum,” said the bank’s chief financial officer, Bruce R. Thompson.

Bank of America’s earnings were driven by decreasing expenses in its mortgage business, signaling that the bank’s housing problems were continuing on the path to recovery.

On Tuesday, Wells Fargo reported fourth-quarter earnings of $5.6 billion, a 10 percent increase in earnings from the same period in 2012, even as the bank’s revenue from home loans showed signs of weakening, Peter Eavis writes in DealBook. The bank reported annual earnings of $21.9 billion, a 16 percent increase over its 2012 profit.

Wells Fargo’s annual earnings exceeded the $17.9 billion annual profit of JPMorgan Chase, which also reported earnings on Tuesday. JPMorgan has been weighed down by legal costs, resulting in a 7.3 percent slide in fourth-quarter earnings, Jessica Silver-Greenberg reports in DealBook. Legal costs totaled $1.1 billion in the quarter, shaving 27 cents a share from the bank’s earnings. The bank reported net earnings of $5.28 billion, or $1.30 a share.

Though JPMorgan and Wells Fargo experienced lackluster mortgage demand in the fourth quarter, they both reported that automobile lending increased. JPMorgan said auto loan origination rose 16 percent to $6.4 billion, and Wells Fargo reported a 26-percent increase year over year to $6.8 billion. But while auto lending is providing some relief to banks, it has also attracted increased regulatory scrutiny, Rachel Abrams writes in DealBook.

With the 2008 financial crisis still very much on their minds, banks remain reluctant to issue new mortgage loans, Mr. Eavis and Ms. Silver-Greenberg write in DealBook.

Though home prices continue to rise and the federal government is supporting the mortgage system, borrowers with less-than-pristine credit scores continue to be denied the American dream of home-ownership by the nation’s largest banks.

Wariness was in full view when JPMorgan and Wells Fargo reported their fourth-quarter results. Wells Fargo, the nation’s largest mortgage lender, reported granting $50 billion in mortgage loans, down 60 percent year over year. Similarly, JPMorgan said it extended $23 billion in mortgages in the quarter, down 55 percent from a year ago.

DOCTOR ADMITS SHARING DATA WITH FORMER SAC TRADER  |  Another witness took the stand on Tuesday in the trial of Mathew Martoma, a former hedge fund manager at SAC Capital Advisors charged with insider trading. Prosecutors contend that the witness, Joel S. Ross, a prominent physician specializing in Alzheimer’s research, passed on confidential information to Mr. Martoma in what the government has called the most lucrative insider trading scheme in American history.

During his testimony, Dr. Ross told the jury of five men and seven women that Mr. Martoma “stood apart” for his knowledge on Alzheimer research, Alexandra Stevenson reports in DealBook.

Whether Mr. Martoma used confidential information to help SAC avoid losses and generate profits of $276 million is not the only question yet to be resolved. Mr. Martoma was expelled from Harvard Law School in 1999 for creating a false transcript, so it remains a mystery how he was then accepted into Stanford Business School, Matthew Goldstein writes in DealBook.

REGULATORS REVISE VOLCKER RULE  |  Federal regulators gave in to the banking industry on Tuesday and announced they had revised a rule that would have required banks to take write-downs on a special type of collateralized-debt obligation, Matthew Goldstein reports in DealBook. The Volcker Rule approved by regulators in December would have required banks to shed their C.D.O.’s backed by trust-preferred securities, or TruPS, and recognize the losses, a rule that had caused an outcry in the banking community.

The new provision would apply to any bank that invested in C.D.O.’s backed by TruPS that were issued by banks with less than $15 billion in assets. The C.D.O.’s must also have been created before May 19, 2010, and a bank must have acquired them before Dec. 10, when the Volcker Rule was completed.

ON THE AGENDA  |  The Producer Price Index for December comes out at 8:30 a.m. Charles Evans, president of the Federal Reserve Bank of Chicago, gives a speech in Coralville, Iowa, at 12:50 p.m. Dennis P. Lockhart, the president of the Atlanta Fed, takes the stage in Atlanta at 5:20 p.m. to discuss the economy and monetary policy. Bank of America reports fourth-quarter earnings before the bell. The Senate holds a hearing at 2 p.m. on regulating financial holding companies and physical commodities. The House Committee on Financial Services holds a hearing at 10 a.m. to discuss the effect of the Volcker Rule on job creation. Robert H. Benmosche, the chief executive of A.I.G., is on Bloomberg TV at 9 a.m.

NEW BOOK BY MICHAEL LEWIS HITS SHELVES IN MARCH  |  Michael Lewis, who wrote “Moneyball,” “Liar’s Poker” and “The Big Short,” is coming out with a new book, “Flash Boys,” on the financial world in March, The New York Times reports. With his publisher’s announcement, Twitter abounded with speculation as to the subject of his book. Many posts pointed to a message board, where it was suggested that the book would be about high-frequency trading.

Mergers & Acquisitions »

How Much Time Warner May Be Worth to a SuitorHow Much Time Warner May Be Worth to a Buyer  |  If Charter Communications hopes to reach a deal to buy Time Warner Cable, it will probably have to pay a higher price based on a crucial measure. DealBook »

Are Potential Cable Mergers Good for Consumers?Are Potential Cable Mergers Good for Consumers?  |  Regulators are bound to look closely at the antitrust issues surrounding any potential cable industry merger, but operators argue that such tie-ups won’t hurt consumer choice. DealBook »

Big Fees for Advisers if Charter Wins Over Time Warner CableBig Fees for Advisers if Charter Wins Over Time Warner Cable  |  Should Charter succeed in its campaign, its advisers stand to reap a bounty of fees. And since analysts and investors appear to believe that any successful bid would end up being higher, those banks could make even more. DealBook »

Google Effect Stirs Several StocksGoogle Effect Stirs Several Stocks  |  A day after Google’s $3.2 billion deal for Nest Labs, the share prices of several companies with related technologies surged. DealBook »

Google Fans the Flame of Connectivity  |  Google’s decision to pay $3.2 billion for Nest Labs will stoke enthusiasm for a future when everyday products and simple gadgets can all be controlled remotely, Robert Cyran of Reuters Breakingviews writes. DealBook »

Eminence Plans Proxy Challenge at Jos. A. BankEminence Plans Proxy Challenge at Jos. A. Bank  |  Eminence Capital, which owns a 4.9 percent stake in Jos. A. Bank, plans to add even more pressure on the menswear retailer by nominating two directors for its board. DealBook »

Elliott Maintains Pressure on Riverbed to Pursue a SaleElliott Maintains Pressure on Riverbed to Pursue a Sale  |  In a letter to the board of Riverbed Technology, Elliott Management again urged the company to either accept a takeover bid of $19 a share or run an auction for itself. DealBook »

INVESTMENT BANKING »

Longtime Morgan Stanley Banker Said to RetireLongtime Morgan Stanley Banker Said to Retire  |  Scott Matlock, a media and telecommunications banker, has decided to retire after 25 years with the investment bank, according to a person familiar with the matter. DealBook »

Reserve Funds Bolster Banks’ Earnings  |  The earnings that JPMorgan Chase and Wells Fargo reported on Tuesday appeared robust, but some of the banks’ profits came not from revenue, but from loan-loss reserves, which the banks set aside in cash during and after the financial crisis to cover future losses, Bloomberg Businessweek reports. BLOOMBERG BUSINESSWEEK

Auto Loans Bring Growth, and Scrutiny, for BanksAuto Loans Bring Growth, and Scrutiny, for Banks  |  Car loan origination jumped at JPMorgan Chase and Wells Fargo in the fourth quarter amid disappointing mortgage demand. DealBook »

PRIVATE EQUITY »

Chinese Firm Considers Bid for United Biscuits  |  Hony Capital, a Chinese private equity firm with $6.8 billion under management, is looking into a bid for United Biscuits Holdings, the British maker of Digestives biscuits, Bloomberg News reports. BLOOMBERG NEWS

Forbes Catches International Eye  |  Forbes Media, the company that includes its namesake magazine, is attracting interest from six different countries from across the globe, The Wall Street Journal writes. Forbes is owned by the Forbes family and the private equity firm Elevation Partners. WALL STREET JOURNAL

Firms Shift Focus to Operating Performance  |  The private equity market is not as robust as it was 10 years ago, with firms posting lower returns and reduced fund fees, Forbes reports. As a result, firms are focusing on the operating performance of their existing portfolio companies, hiring individuals with operating expertise. FORBES

HEDGE FUNDS »

SPX Reaches Accord With Relational Over Board SeatsSPX Reaches Accord With Relational Over Board Seats  |  The industrial equipment maker SPX Corporation said on Tuesday that it had reached an agreement with the activist investment fund Relational Investors that could give the firm up to two board seats over the next two years. DealBook »

Activist Investor Takes Bob Evans Farms to CourtActivist Investor Takes Bob Evans Farms to Court  |  After two foiled attempts to pressure the board to make changes to its restaurant and packaged goods business, Sandell Asset Management filed a lawsuit on Tuesday. DealBook »

SAC’s Cohen Enjoys a Different Type of Court SceneSAC’s Cohen Enjoys a Different Type of Court Scene  |  Steven A. Cohen, the billionaire founder of SAC Capital Advisors, took time to catch a Knicks game. Perhaps it was a distraction from the legal turmoil surrounding his firm. DealBook »

Nader, an Adversary of Capitalism, Now Fights as an InvestorNader, a Gadfly of Capitalism, Now Fights as an Investor  |  The consumer advocate Ralph Nader has taken on a new fight: shareholder rights, which he sees as a natural extension of his work. DealBook »

I.P.O./OFFERINGS »

Japanese Company Backed by Cerberus Said to Plan I.P.O.  |  The Japanese railroad and property company Seibu Holdings is said to be planning an initial public offering in Tokyo in the next few months, The Wall Street Journal writes, citing unidentified people familiar with the situation. The I.P.O. would end the company’s long dispute with its largest shareholder, the private equity firm Cerberus, over taking the company public. WALL STREET JOURNAL

Jakarta’s Blue Bird Taxis Looks to I.P.O.  |  Blue Bird, whose taxis rumble through the streets of Jakarta, is planning to sell $400 million of its business in an initial public offering, giving the company a market capitalization of $2 billion, The Financial Times reports. FINANCIAL TIMES

Twitter Was Fourth-Largest I.P.O. in 2013  |  Despite the hype, Twitter was only the fourth-largest initial public offering in 2013, Bloomberg News reports in a list. Plains GP Holdings, an oil pipeline holding company, topped the list, followed by Hilton Worldwide and Zoetis, a pharmaceuticals company. BLOOMBERG NEWS

VENTURE CAPITAL »

Former Lululemon C.E.O. to Head Start-Up  |  Christine Day, the former chief executive of Lululemon, who resigned seven months ago, will become the chief executive of a healthy food start-up called Luvo, Forbes reports. Luvo is a new venture from the investment banker Stephen Sidwell. FORBES

Supplier to Data Centers Raises $101 Million  |  Nutanix, which supplies infrastructure products to data centers, has raised $101 million led by SAP Ventures and Riverwood Capital in its fourth round of venture capital funding, bringing its funding total to $172 million, ReCode reports. The investment values the company at $1 billion. RECODE

U.S. Marine Corps Offers Model for Start-Up Recruitment  |  While most start-ups cannot afford to pay their employees competitive salaries, many still manage to recruit top talent by employing similar techniques as the United States Marine Corps and the Peace Corps, John Greathouse writes in The Wall Street Journal. WALL STREET JOURNAL

LEGAL/REGULATORY »

Europe Reaches Agreement on Trading of DerivativesEurope Reaches Agreement on Trading of Derivatives  |  The regulations will limit attempts by speculators to corner the market in raw materials like corn or grain. DealBook »

Deutsche Bank Suspends Traders Amid Foreign Exchange Investigations  |  Deutsche Bank has suspended several traders in New York amid a series of investigations into potential manipulation of the $5-trillion-a-day foreign exchange market, according to a person briefed on the matter. DealBook »

For 2 Wall Street Regulators, More Belt-TighteningFor 2 Wall Street Regulators, More Belt-Tightening  |  Under the new budget proposal, the S.E.C. and the Commodity Futures Trading Commission would receive less money this year than President Obama had requested. DealBook »

Fed Considers Regulations on Commodities  |  The Federal Reserve said it was evaluating regulations that would impose capital charges and insurance requirements on banks’ physical commodities trading, The Financial Times reports. Lawmakers and Wall Street opponents argue that banks that trade, warehouse and transport physical commodities pose a risk to the financial system. FINANCIAL TIMES

F.B.I. Suspects Traders of Front-Running Fannie and Freddie  |  Wall Street traders may be manipulating the interest rate swap market, a derivatives market, to bolster their banks’ revenue by front-running transactions made by the United States mortgage giants Fannie Mae and Freddie Mac, Reuters reports. The disclosure came in an F.B.I. bulletin, which detailed the traders’ method of alerting each other of impending transactions so they could place orders first. REUTERS

New York Court to Hear Case on Foreign Bank Assets  |  The New York Court of Appeals will decide whether banks operating in New York would have to turn over to litigants assets held in their foreign branches, Reuters reports. The ruling could have broad implications for the global banking industry. REUTERS



Going to the Mattresses

Mattress merger would be king-size pain for Sleepy’s | New York Post

With your existing account from...

{* loginWidget *}

Welcome back!

{* welcomeName *}

{* #registrationForm *} {* traditionalRegistration_emailAddress *} {* traditionalRegistration_password *} {* traditionalRegistration_passwordConfirm *} {* traditionalRegistration_displayName *} {* traditionalRegistration_captcha *} {* traditionalRegistration_ageVerification *} By clicking "Create Account", you confirm that you accept our terms of service and have read and understand privacy policy. {* /registrationForm *}

Don't worry, it happens. We'll send you a link to create a new password.

{* #forgotPasswordForm *} {* traditionalSignIn_emailAddress *} {* /forgotPasswordForm *}

We've sent an email with instructions to create a new password. Your existing password has not been changed.

{* mergeAccounts *}



Wall Street Work Habits Show Generation Gap

“If you love what you do, it’s not ‘work,” David M. Rubenstein, the co-founder and co-chief executive of the private equity giant Carlyle Group, told CNBC’s Squawk Box on Tuesday.

It is a refrain he’s repeated many times over the years, although it may never have been more appropriate than it is now, as Wall Street firms make a show of re-evaluating the grueling hours long suffered by their junior employees.

But the remarks also hint at two Wall Streets: An older group well-accustomed to the long hours it takes to get to the top, and a younger crowd that increasingly wants meaningful work and the flexibility afforded by technology. One senior executive went so far as to refer to it as an “entitlement” among the new class of recruits.

“There’s a huge gap across the generations in terms of how people look at the whole question of time and commitment and what that means,” said Stewart D. Friedman, director of the Wharton work-life integration project and the author of “Baby Bust: New Choices for Men and Women in Work and Family.”

But young people don’t necessarily expect to work less than the generations before them, a Wharton study shows. Students graduating in 1992 expected to work 58 hours a week, compared with 72 hours in 2012, according to the survey of undergraduates at the time. And 78 percent of the older generation expected to have children, compared with only 42 percent in 2012.

At the same time, young people don’t expect to move as high up the corporate ladder.

“The expected rise in terms of how far you’re going to advance in a company’s hierarchy is lower now than it was 20 years ago,” Mr. Friedman said. “People have lower aspirations, and just not in work but in their family lives.”

It’s no secret that junior bank analysts and traders work grueling hours to score the big paychecks that lured them to Wall Street. But those paychecks have gotten a bit smaller since the financial crisis, and young people have increasingly flocked to other industries like technology, private equity and hedge funds.

Now, experts say, young people are putting less emphasis on making money and more on finding work that is meaningful to them. They understand that late nights and weekends might be required, but they also want the flexibility that technology can afford - the ability to work remotely, for instance, and to connect easily with others.

“Our students are willing to work really hard,” said Regina Resnick, the associate dean of the career management center at Columbia. “It’s not a matter of hard work, it’s a matter of how one works.”

Wall Street’s round-the-clock work habits have also suffered a public relations crisis. The death of a Bank of America intern last year spurred many firms to re-evaluate their policies on working hours. (The intern had reportedly worked day and night before his death, and an inquest later determined he had died of a seizure).

“People are just more disaffected now with that kind of lifestyle and want to have a greater sense of control,” Mr. Friedman said. “Where companies don’t provide that sense of meaning and purpose, their brand as employer is weakened. They’re not going to be able to compete for the best and the brightest.”

Goldman Sachs and Bank of America have urged junior employees to take more weekend time off. On Monday, Credit Suisse sent out an internal note discouraging its low-level employees from working on Saturdays, except for “live deals.”

There’s a question of whether any of these efforts to improve work-life balance will have any effect in practice.

“How much of a bright line will there be between a live deal and just an important pitch? There can be a gray area sometimes between what is live and what isn’t,” one Credit Suisse analyst told DealBook on Monday. “The enforcement mechanism is what people will be really looking at.”

Still others have more radical suggestions: Let junior bankers sleep all day on weekdays, since they end up staying up all night working anyway.

“Really you could cut out that whole 9-to-7 shift and just pitch up at 7 p.m. ready to eat dinner and do a full 8-hour day of work,” wrote Bloomberg’s Matt Levine on Tuesday. “I mean, not really, but sometimes.”

Mr. Friedman and Ms. Resnick and others, however, praise Wall Street’s efforts to rein in some of the more extreme work habits.

“The long-standing tradition of 100-hour work weeks, that’s not going to be easy to change, but I applaud these efforts,” Mr. Friedman said. “The young people, after two years in an analyst program at a bank on Wall Street, they’re burnt out, they’re saying ‘I don’t want to live like this.’”